Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort

Prevalence of diabetes in the elderly increases, and half of the French diabetics are over the age of 75 years. The GERODIAB study is the first French multicentre, prospective, observational study designed to analyse over 5 years the influence of glycaemic control on morbidity–mortality in type 2 di...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fundamental & clinical pharmacology 2016-02, Vol.30 (1), p.76-81
Hauptverfasser:	Doucet, Jean A., Bauduceau, Bernard, Le Floch, Jean-Pierre, Verny, Christiane
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Age Factors Aged Aged, 80 and over ageing Blood Glucose - analysis Cohort Studies Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - mortality Drug Therapy, Combination Female France - epidemiology GERODIAB Glucagon-Like Peptide 1 - administration & dosage Glucagon-Like Peptide 1 - adverse effects Glucagon-Like Peptide 1 - analogs & derivatives Glucagon-Like Peptide 1 - therapeutic use Glycated Hemoglobin A - analysis Health Services for the Aged Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use insulin Insulin - administration & dosage Insulin - adverse effects Insulin - therapeutic use Male oral antidiabetic drugs Prevalence Prospective Studies type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!